These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35349073)
1. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens. Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073 [TBL] [Abstract][Full Text] [Related]
2. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India. Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087 [TBL] [Abstract][Full Text] [Related]
3. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens. Saha U; Gondi R; Patil A; Saroj SD Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207 [TBL] [Abstract][Full Text] [Related]
4. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa. Founou RC; Founou LL; Allam M; Ismail A; Essack SY Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772 [TBL] [Abstract][Full Text] [Related]
5. Investigating the mobilome in clinically important lineages of Enterococcus faecium and Enterococcus faecalis. Mikalsen T; Pedersen T; Willems R; Coque TM; Werner G; Sadowy E; van Schaik W; Jensen LB; Sundsfjord A; Hegstad K BMC Genomics; 2015 Apr; 16():282. PubMed ID: 25885771 [TBL] [Abstract][Full Text] [Related]
6. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections. Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004 [TBL] [Abstract][Full Text] [Related]
7. Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine. Price VJ; McBride SW; Hullahalli K; Chatterjee A; Duerkop BA; Palmer KL mSphere; 2019 Jul; 4(4):. PubMed ID: 31341074 [TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens. Pursey E; Dimitriu T; Paganelli FL; Westra ER; van Houte S Philos Trans R Soc Lond B Biol Sci; 2022 Jan; 377(1842):20200464. PubMed ID: 34839714 [TBL] [Abstract][Full Text] [Related]
9. The ESKAPE mobilome contributes to the spread of antimicrobial resistance and CRISPR-mediated conflict between mobile genetic elements. Botelho J; Cazares A; Schulenburg H Nucleic Acids Res; 2023 Jan; 51(1):236-252. PubMed ID: 36610752 [TBL] [Abstract][Full Text] [Related]
10. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Miller WR; Arias CA Nat Rev Microbiol; 2024 Oct; 22(10):598-616. PubMed ID: 38831030 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health. Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823 [TBL] [Abstract][Full Text] [Related]
12. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens. Kondo K; Kawano M; Sugai M mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073 [TBL] [Abstract][Full Text] [Related]
13. Intercellular Transfer of Chromosomal Antimicrobial Resistance Genes between Acinetobacter baumannii Strains Mediated by Prophages. Wachino JI; Jin W; Kimura K; Arakawa Y Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138576 [TBL] [Abstract][Full Text] [Related]
14. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens. Mortensen K; Lam TJ; Ye Y Front Microbiol; 2021; 12():758782. PubMed ID: 34759910 [TBL] [Abstract][Full Text] [Related]
15. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms. Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858 [No Abstract] [Full Text] [Related]
16. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform. Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens. Michiels JE; Van den Bergh B; Verstraeten N; Fauvart M; Michiels J Antimicrob Agents Chemother; 2016 Aug; 60(8):4630-7. PubMed ID: 27185802 [TBL] [Abstract][Full Text] [Related]
18. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update. Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. Pandey R; Mishra SK; Shrestha A Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185 [TBL] [Abstract][Full Text] [Related]
20. ESKAPE in China: epidemiology and characteristics of antibiotic resistance. Luo Q; Lu P; Chen Y; Shen P; Zheng B; Ji J; Ying C; Liu Z; Xiao Y Emerg Microbes Infect; 2024 Dec; 13(1):2317915. PubMed ID: 38356197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]